Merrimack Announces Top-Line Results from Randomized Phase 2 Trial of MM-141 in Front-Line Metastatic Pancreatic Cancer

Stock Information for Merrimack Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.